Vaccine advisory group OKs AstraZeneca vaccine for adults 30 and over – April 23, 2021
AstraZeneca, COVID-19, COVID-19 vaccines, NACI, briefing, coronavirus, covid-19 vaccine, outbreak, pandemic, update, vaccine rollout
During a virtual news conference, members of the National Advisory Committee on Immunization (NACI) join Dr. Howard Njoo, Canada’s deputy chief public health officer, for an update on recommendations regarding the AstraZeneca COVID-19 vaccine. Taking part in the briefing are Drs. Caroline Quach-Thanh, chair of NACI, Shelley Deeks, vice-chair of NACI, and Bonnie Henry, provincial health officer for British Columbia. NACI recommends that the AstraZeneca vaccine may be offered to individuals 30 years of age and older if the individual does not wish to wait for an mRNA vaccine and if the benefits outweigh the risks. NACI’s previous recommendation advised against the use of this vaccine on people under age 55; nevertheless, some provinces lowered the minimum age eligibility to 40.